Document Detail


The Management of Antithrombotic Medication in Skin Surgery.
MedLine Citation:
PMID:  22734794     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: Approximately one in four patients undergoing dermatologic surgery takes an antithrombotic medication. When approaching the management of antithrombotic agents, procedural dermatologists must balance surgical outcomes, bleeding risks, and cardiovascular protection. Continuing antithrombotics during surgery increases the risk hemorrhage, but discontinuation of these agents may increase the risk of thrombotic events. Despite increasing evidence for continuation of antithrombotics during dermatologic surgery, few official guidelines exist, and clinicians have been slow to integrate new evidence into clinical practice. A study in 2007 reported that more than 40% of dermatologic surgeons sometimes discontinue warfarin for surgery. OBJECTIVE: This article reviews antithrombotic agents in the United States and summarize perioperative management recommendations of antithrombotic agents in skin surgery. MATERIALS AND METHODS: A review of the literature was performed focused on antithrombotic medications commercially available in the United States, including the two newest agents, dabigatran and rivaroxaban. CONCLUSION: Although there are concerns regarding bleeding, there are no reports of life-threatening hemorrhage from continued antithrombotic therapy in dermatologic surgery. Furthermore, potentially fatal cardiovascular events after cessation of medically indicated antithrombotic medications are increasingly recognized, leading to the growing acceptance that the risk of stopping most antithrombotics may outweigh the risks of bleeding incurred by continuing antithrombotic therapy.
Authors:
Shields Callahan; Anne Goldsberry; Glen Kim; Simon Yoo
Related Documents :
7406384 - Communication skills of house officers. a study in a medical clinic.
16018354 - Psoriatic arthritis in a military aviator.
22533344 - Non drowsy obstructive sleep apnea as a potential cause of resistant hypertension: a ca...
3787294 - Intern ranking versus subsequent house officer performance.
17688714 - The problem surgical colleague.
17569684 - Trends in the golden state: small-group premiums rise sharply while actuarial values fo...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-6-26
Journal Detail:
Title:  Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]     Volume:  -     ISSN:  1524-4725     ISO Abbreviation:  -     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-6-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9504371     Medline TA:  Dermatol Surg     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 by the American Society for Dermatologic Surgery, Inc. Published by Wiley Periodicals, Inc.
Affiliation:
Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cerebral Motor Function in Very Premature-at-Birth Adolescents: A Brain-Stimulation Exploration of K...
Next Document:  A Supramolecular Complex Coupled to a Metal-Nanoparticle: Computational Studies on the Optical Absor...